In our series of podcasts, FIECON team members engage with patient advocates and thought leaders to explore the burden, unmet needs, patient journey, and potential future treatments for specific diseases, with the aim of gaining a deeper understanding of the patient's perspective, particularly for rare diseases. At FIECON, we are dedicated to ensuring that life-changing treatments reach the patients who truly need them, while also increasing awareness and amplifying the patient voice to make ...
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
These podcasts have the highlights of every weekly service at South Church in New Britain, CT. These podcasts will contain the sermon and sometimes the Chancel Choir anthem each week.
…
continue reading
Tired of the grind. Tired of feeling down. Tired of thinking bad about yourself. I help women, and men, to overcome self-doubt through confidence training, leadership lessons, mindset, goals setting, visualization and learning about how the law of attraction can improve life. I often do interviews of successful people, as well as therapists, to present ideas to help you design the life you want.If you're afraid to show up, this show is for you. If you need to learn to love yourself, this sho ...
…
continue reading
Welcome to our new podcast, TechTalks! The podcast series designed to educate, inspire, and engage new conversations about technology and how it is an enabler for our economy, building our talented workforce, creating growth in our IT sector, and attracting talent in our post-secondary institutions. The podcast will create new connections between employers, students, entrepreneurs, investors and our business community. Our podcast content will appeal to the business community, students, entr ...
…
continue reading
Postlude: "Prelude & Fugue in F major" - by Johann Ludwig Krebs (formerly attr. J.S. Bach) Frank Zilinyi, OrganistBy South Congregational - First Baptist Church
…
continue reading
1
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME credits: 1.00 Valid until: 10-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/spinal-muscular-atrophy-optimizing-the-management-of-adults-in-the-era-of-disease-modifying-therapies/26352/ Explore this on-demand webcast for an in-depth expert presentation and case discussion. This educational initiative is designed to help neuro…
…
continue reading
1
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Host: Perry Shieh, MD, PhD Explore this on-demand webcast for an in-depth expert presentation and case discussion. This educational initiative is designed to help neurologists enhance their clinical approach by providing individualized, evidence-based care for adult SMA patients. Gain insights into the latest treatment options, safety and efficacy …
…
continue reading
Scripture: Micah 6:1-8 & Matthew 5:1-12 Sermon: "Beautiful Dreamers" by Rev. Kathleen Peters Prelude: "Chorale Prelude on 'We Now Implore the Holy Ghost'" by Dietrich Buxtehude Postlude: "Toccata in F" by Dietrich Buxtehude Organist: Frank Zilinyi, DirectorBy Rev. Kathy Peters
…
continue reading
Host: Jennifer Caudle, DO Guest: Patricia A. Mangan, RN, MSN, APRN-BC The expansion of treatment options and strategies across the disease continuum is good news for patients who previously had few options; however, it can be a challenge for clinicians to stay up–to date in this very dynamic setting.…
…
continue reading
CME credits: 1.00 Valid until: 02-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/multiple-myeloma-care-translating-evolving-practices-to-oncology-nurses-in-community-settings/24150/ The expansion of treatment options and strategies across the disease continuum is good news for patients who previously had few options; however, it …
…
continue reading
Scripture: Luke: 18:9-14 Sermon: "The Heart of the Prayer" by Rev. Kathleen Peters Anthem: "There is a Balm in Gilead" by Harry T. Burleigh Soloist: Cynthia Mellon, Mezzo-Soprano, Frank Zilinyi, DirectorBy Rev. Kathy Peters
…
continue reading
Anthem: "There is a Balm in Gilead" by Harry T. Burleigh Soloist: Cynthia Mellon, Mezzo-Soprano, Frank Zilinyi, DirectorBy Rev. Kathy Peters
…
continue reading
Scripture: Acts: 11:1-18 Sermon: "Church In Times Of Change: Discerning" by Rev. Jane H. Rowe Anthem: "Don't You Weep When I Am Gone" by Harry T. Burleigh Soloist: Mark Hale, Tenor, Frank Zilinyi, DirectorBy Rev. Jane H. Rowe
…
continue reading
Anthem: "Don't You Weep When I Am Gone" by Harry T. Burleigh Soloist: Mark Hale, Tenor, Frank Zilinyi, DirectorBy South Congregational - First Baptist Church
…
continue reading
CME credits: 1.25 Valid until: 05-02-2025 Claim your CME credit at https://reachmd.com/programs/cme/practice-changing-highlights-in-ggej-cancers-the-latest-data-from-chicago/26438/ The therapeutic landscape for gastric and gastroesophageal junction (G/GEJ) cancer is rapidly evolving, with biomarkers directing treatment selection. Recent evidence su…
…
continue reading
Host: Samuel J. Klempner, MD The therapeutic landscape for gastric and gastroesophageal junction (G/GEJ) cancer is rapidly evolving, with biomarkers directing treatment selection. Recent evidence suggests that the combination of HER2-targeted therapies and immune checkpoint inhibitors has synergistic effects, highlighting the importance of the most…
…
continue reading
1
The patient journey | Metastatic breast cancer
41:38
41:38
Play later
Play later
Lists
Like
Liked
41:38
In this episode Karl Freemyer, BD director at FIECON, is speaking with Emma Chaffin about her experience living with the metastatic breast cancer as a biopharmaceutical executive. Emma is a resilient breast cancer survivor who was diagnosed with stage 4 breast cancer five years ago at the age of 41. Facing a daunting prognosis and a treatment plan …
…
continue reading
1
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Guest: Jessica Griffiths, PA-C Guest: Anna L. Rourke, NP The BeAT-HF clinical trial showed that Barostim plus GDMT resulted in significant and meaningful improvements in exercise capacity, functional status, and quality of life. Learn best practices from advanced practice providers for successfully integrating Barostim into your clinical practice.…
…
continue reading
Scripture: Acts: 8:4-8, 14-17, 26-39 Sermon: "Church In Times Of Change: Including" by Rev. Jane H. Rowe Anthem: "Come, O Come, Our Voices Raise" by Alec Wyton Soloist: Jordan Rose Lee, Frank Zilinyi, DirectorBy Rev. Jane H. Rowe
…
continue reading
Anthem: "Come, O Come, Our Voices Raise" by Alec Wyton Soloist: Jordan Rose Lee, Frank Zilinyi, DirectorBy South Congregational - First Baptist Church
…
continue reading
Scripture: Acts: 6:1-7 Sermon: "Church In Times Of Change: Serving" by Rev. Jane H. Rowe Anthem: "I Sing Because I'm Happy" by Rollo Dilworth South Church Chancel Choir, Frank Zilinyi, DirectorBy Rev. Jane H. Rowe
…
continue reading
Anthem: "I Sing Because I'm Happy" by Rollo Dilworth South Church Chancel Choir, Frank Zilinyi, DirectorBy South Congregational - First Baptist Church
…
continue reading
Introit: "Abendlied" by Joseph Gabriel Rheinberger South Church Chancel Choir, Frank Zilinyi, DirectorBy South Congregational - First Baptist Church
…
continue reading
Host: Diana V. Do, MD Guest: Peter K. Kaiser, MD This case consult with Dr Do and Dr Kaiser will consider a treatment-experienced patient referred for a 2nd opinion with decreased vision and prior diagnosis of neovascular AMD (nAMD). Dr Do and Dr Kaiser will discuss the recently approved anti-vascular endothelial growth factor (VEGF) agents with gr…
…
continue reading
CME credits: 0.25 Valid until: 07-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/improving-adherence-and-persistence-with-durable-anti-vegf-therapies-for-namd/18068/ This case consult with Dr Do and Dr Kaiser will consider a treatment-experienced patient referred for a 2nd opinion with decreased vision and prior diagnosis of neov…
…
continue reading
Scripture: Mark: 3:31-35 Sermon: "South Church: Living the Stories of God's Love" by Rev. John Madsen-Bibeau Introit: "Bless the Lord, O My Soul" by Mikhail Ippolitov-Ivanov South Church Chancel Choir, Frank Zilinyi, DirectorBy Rev. John Madsen-Bibeau
…
continue reading
Introit: "Bless the Lord, O My Soul" by Mikhail Ippolitov-Ivanov South Church Chancel Choir, Frank Zilinyi, DirectorBy South Congregational - First Baptist Church
…
continue reading
1
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting
CME credits: 0.50 Valid until: 30-05-2025 Claim your CME credit at https://reachmd.com/programs/cme/cd20-x-cd3-bispecificsredefining-treatment-for-patients-with-rr-dlbcllbcl-in-the-community-setting/17877/ In the rapidly evolving landscape of treating patients with relapsed or refractory large/diffuse large B-cell lymphoma (R/R LBCL/DLBCL), recent …
…
continue reading
1
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting
Host: Matthew Lunning, DO, FACP In the rapidly evolving landscape of treating patients with relapsed or refractory large/diffuse large B-cell lymphoma (R/R LBCL/DLBCL), recent advancements are providing newfound hope. Immunochemotherapy with R-CHOP has long been the standard first-line treatment, but a significant portion of patients experience rel…
…
continue reading
CME credits: 0.25 Valid until: 30-05-2025 Claim your CME credit at https://reachmd.com/programs/cme/evolving-our-view-of-the-coagulation-cascade-and-stroke-management/24144/ How can you improve long-term secondary stroke prevention in patients with a history of noncardioembolic ischemic stroke or transient ischemic attack (TIA)? An understanding of…
…
continue reading
Host: Valeria Caso, MD, PhD Guest: Ashkan Shoamanesh, MD How can you improve long-term secondary stroke prevention in patients with a history of noncardioembolic ischemic stroke or transient ischemic attack (TIA)? An understanding of how to apply emerging clinical trial data is critical, as is the evaluation of potential alternative agents that cou…
…
continue reading
1
Consensus Recommendations for Use of p16/Ki67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
CME credits: 0.25 Valid until: 29-05-2025 Claim your CME credit at https://reachmd.com/programs/cme/consensus-recommendations-for-use-of-p16ki67-dual-staining-cytology-in-the-management-of-individuals-testing-positive-for-hpv/14675/ More effective triage tests are essential to improving cervical cancer risk-stratification and thus reducing the pote…
…
continue reading
1
Consensus Recommendations for Use of p16/Ki67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
Host: Warner K. Huh, MD Guest: Kimberly Levinson, MD, MPH More effective triage tests are essential to improving cervical cancer risk-stratification and thus reducing the potential for unnecessary colposcopies. Enduring consensus cervical cancer screening recommendations, published in 2024, describe specific-use algorithms for p16/Ki-67 dual-staini…
…
continue reading
Season of Renewal: Our Weakness, God's Power Scripture: Acts: 2:36-47 Sermon: "Be Saved!" by Rev. Jane H. Rowe Anthem: "I Want To Walk As A Child of the Light" by Kathleen Thomerson arr. Paul ManzBy South Congregational - First Baptist Church
…
continue reading
Anthem: "I Want To Walk As A Child of the Light" by Kathleen Thomerson arr. Paul Manz South Church Chancel Choir, Frank Zilinyi, DirectorBy South Congregational - First Baptist Church
…
continue reading
CME credits: 0.25 Valid until: 22-05-2025 Claim your CME credit at https://reachmd.com/programs/cme/strategic-excellence-mastering-the-expanding-attr-cm-therapeutic-landscape-in-pharmacy-practice/18124/ Join us in this educational endeavor to empower pharmacists with the latest insights and strategies for improved decision-making in ATTR-CM managem…
…
continue reading
Host: Hongya Chen, PharmD Guest: Jennifer Day, PharmD Guest: Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA Join us in this educational endeavor to empower pharmacists with the latest insights and strategies for improved decision-making in ATTR-CM management. The program emphasizes the latest clinical insights in this evolving therapeutic landscap…
…
continue reading
Season of Renewal: Our Weakness, God's Power Scripture: Scripture: 2 Corinthians 12:6-10 Sermon: "Our Weakness, God's Power" by Rev. Dr. Harry L. Riggs, II Anthem: "He Never Failed Me Yet" by Robert Ray Soloist: Jordan Rose Lee, SopranoBy Rev. Dr. Harry L. Riggs, II
…
continue reading
Anthem: "He Never Failed Me Yet" by Robert Ray Soloist: Jordan Rose Lee, Soprano South Church Chancel Choir, Frank Zilinyi, DirectorBy South Congregational - First Baptist Church
…
continue reading
CME credits: 1.00 Valid until: 25-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/resolving-practice-barriers-to-consolidative-immunotherapy-in-stage-iii-nsclc/24386/ In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectabili…
…
continue reading
Host: Joshua E. Reuss, MD In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
…
continue reading
CME credits: 1.00 Valid until: 25-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/differentiating-and-managing-pneumonitis-in-unresectable-stage-iii-nsclc-case-discussion/24393/ In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining …
…
continue reading
Host: Jhanelle E. Gray, MD In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
…
continue reading
Host: Jhanelle E. Gray, MD Guest: Joshua E. Reuss, MD In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
…
continue reading
Host: Joshua E. Reuss, MD In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
…
continue reading
Host: Joshua E. Reuss, MD Guest: Jhanelle E. Gray, MD In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
…
continue reading
CME credits: 1.00 Valid until: 25-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/accurate-staging-and-determining-resectability-in-nsclc/24385/ In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical …
…
continue reading
CME credits: 1.00 Valid until: 25-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/consolidative-immunotherapy-following-scrt-vs-rt-only-in-stage-iii-nsclc/24388/ In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, a…
…
continue reading
CME credits: 1.00 Valid until: 25-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/optimizing-consolidative-immunotherapy-in-unresectable-stage-iii-nsclc-case-discussion/24392/ In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining re…
…
continue reading
Host: Joshua E. Reuss, MD In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
…
continue reading
CME credits: 1.00 Valid until: 25-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/consolidative-immunotherapy-in-unresectable-stage-iii-nsclc-with-oncogenic-drivers/24391/ In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resect…
…
continue reading
Host: Jhanelle E. Gray, MD Guest: Joshua E. Reuss, MD In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
…
continue reading
CME credits: 1.00 Valid until: 25-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/consolidation-immunotherapy-after-concurrent-crt-what-do-real-world-data-show/24387/ In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectabili…
…
continue reading
CME credits: 1.00 Valid until: 25-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/immunotherapy-approaches-in-unresectable-stage-iii-nsclc-whats-on-the-horizon/24390/ In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectabili…
…
continue reading